Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis

Autonomic Neuroscience: Basic and Clinical

Volumn 143, Issue 1-2, 2008, Pages 58-67

  Holman, Andrew J ^a   Ng, Edmund ^b  

^a Pacific Rheumatology Research   (United States)

^b Edmund Ng Associates   (United States)

Author keywords

Anti TNF therapy; Heart rate variability; Psoriatic arthritis; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ETANERCEPT; INFLIXIMAB; TUMOR NECROSIS FACTOR;

ADRENERGIC SYSTEM; ADULT; ARTICLE; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEART RATE VARIABILITY; HUMAN; IMMUNOTHERAPY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RHEUMATOID ARTHRITIS; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; AUTONOMIC NERVOUS SYSTEM; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECEPTORS, TUMOR NECROSIS FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; TUMOR NECROSIS FACTORS;

EID: 56249100681     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2008.05.005     Document Type: Article

References (34)

1. Abrams B. Long-term sleep apnea as a pathologic factor for cell-mediated autoimmune disease. Med. Hypotheses 65 6 (2005) 1024-1027
2. Anderson J.J., Wells G., Verhoeven A.C., and Felson D.T. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum. 43 1 (2000) 22-29
3. Barendregt P.J., van der Meiracker A.H., Markusse H.M., et al. Parasympathetic failure does not contribute to ocular dryness in primary Sjogren's syndrome. Ann. Rheum. Dis. 58 (1999) 746-750
4. Barendregt P.J., Tulen J.H.M., van der Meiracker A.H., and Markusse H.M. Spectral analysis of heart rate and blood pressure variability in Sjogren's syndrome. Ann. Rheum. Dis. 61 (2002) 232-236
5. Berkoff D.J., Mall N., Moorman C.T., and Cairns C.B. Easy accessible and accurate method to assess heart rate variability in humans. Acad. Emerg. Med. 12 5 (2005) 88 suppl
6. Chung M.K., Gulick T.S., and Rotondo R.E. Mechanism of action of cytokine inhibition of β-adrenergic stimulation of cyclic AMP in rat cardiac monocytes: impairment of signal transduction. Circ. Res. 67 (1990) 753-763
7. Czura C.J., and Tracey K.J. Autonomic neural regulation of immunity. J. Intern. Med. 257 2 (2005) 156-166
8. di Comite G., Marinosci A., Di Matteo P., et al. Neuroendocrine modulation induced by selective blockade of TNF-alpha in rheumatoid arthritis. Ann. N. Y. Acad. Sci. 1069 (2006) 428-437
9. Elenkov I.J., Wilder R.L., Chrousos G.P., and Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and immune system. Pharmacol. Rev. 52 (2000) 595-638
10. Evrengul H., Dursunoglu D., Cobankara V., et al. Heart rate variability in patients with rheumatoid arthritis. Rheumatol. Int. 24 (2004) 198-202
11. Felson D.T., Anderson J.J., Boers M., et al. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum. 38 6 (1995) 727-735
12. Hamaad A., Sosin M., Blann A.D., Patel J., Lip G.Y.L., and MacFadyen R.J. Markers of inflammation in acute coronary syndromes: association with increased heart rate and reductions in heart rate variability. Clin. Cardiol. 28 (2005) 570-576
13. Janszky I., Ericson M., Lekander M., et al. Inflammatory markers and heart rate variability in women with coronary heart disease. J. Intern. Med. 256 (2004) 421-428
14. Lagana B., Tubani L., Mafeo N., et al. Heart rate variability and cardiac autonomic function in systemic lupus erythematosis. Lupus 5 (1996) 49-55
15. Lanza G.A., Sgueglia G.A., Cianflone D., et al. Relation of heart rate variability to serum levels of C-reactive protein in patients with unstable angina. Am. J. Cardiol. 97 (2006) 1702-1706
16. Lindqvist A., Erkolahti R., Heinonen E., and Valimaki I. Reactivity of autonomic nervous control of heart rate in diabetes mellitus and juvenile rheumatoid arthritis. Scand. J. Clin. Invest. 46 (1986) 771-777
17. Malik M., et al., for The task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, and clinical use. Circulation 93 (1996) 1043-1065
18. Maradit-Kremers H., Crowson C.S., Nicola P.J., et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 52 2 (2005) 402-411
19. Malave H.A., Taylor A.A., Nattama J., Deswal A., and Mann D.L. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability. Chest 123 (2003) 716-724
20. Murray D.R. What is 'heart rate variability" and is it blunted by tumor necrosis factor?. Chest 123 (2003) 664-666
21. Niemela R.K., Hakala M., Huikuri H.V., and Juhani Airaksinen K.E. Comprehensive study of autonomic function in a population with primary Sjogren's syndrome. No evidence of autonomic involvement. J. Rheumatol. 30 (2003) 74-79
22. Parnes E.I., Krasnosel'skii M.I., Tsurko V.V., and Stuik R.I. Long-term prognosis in patients with rheumatoid arthritis depending on baseline variability in cardiac rhythm. Ter. Arh. 77 9 (2005) 77-80
23. Pincus T., Swearingen C., and Wolfe F. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum. 42 10 (1999) 2220-2230
24. Prevoo M.L., van't Hof M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., and van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 38 1 (1995) 44-48
25. Sajadieh A., Wendelboe Nielsen O., Rasmussen V., Hein H.O., Abedini S., and Fischer Hansen J. Increased heart rate and reduced heart-rate variability are associated with subclinical inflammation in middle-aged and elderly subjects with no apparent heart disease. Eur. Heart J. 25 (2004) 363-370
26. Shimizu M., Tachibana N., Hagasaka Y., and Goto M. Obstructive sleep apnea in RA patients and effect of CPAP on RA activity [abstract]. Arthritis Rheum. 48 9 suppl (2003) S114
27. Smolen J.S., and Aletaha D. Challenges of predicting treatment response in patients with rheumatoid arthritis. Nat Clin Pract Rheumatol 1 2 (2005) 62-63
28. Straub R.H., and Cutolo M. Circadian rhythms in rheumatoid arthritis: implications for pathophysiology and therapeutic management. Arthritis Rheum. 56 2 (2007) 399-408
29. Straub R.H., and Cutolo M. Does stress influence the course of rheumatic diseases?. Clin. Exp. Rheumatol. 24 3 (2006) 225-228
30. Straub R.H., Dhabhar F.S., Bijlsma J.W., and Cutolo M. How psychological stress via hormones and nerve fibers may exacerbate rheumatoid arthritis. Arthritis Rheum. 52 1 (2005) 16-26
31. Stein K.S., McFarlane I.C., Goldberg N., and Ginzler E.M. Hart rate variability in patients with systemic lupus erythematosis. Lupus 5 (1996) 44-48
32. Tumiati B., Perazzoli F., Negro A., Panaleoni M., and Regolisti G. Heart rate variability in patients with Sjogren's syndrome. Clin. Rheumatol. 19 (2000) 477-480
33. Vassilopoulos D., and Mantzoukis D. Dialogue between the brain and the immune system in inflammatory arthritis. Ann. N. Y. Acad. Sci. 1088 (2006) 132-138
34. Yildirir A., Aksoyek S., Calguneri K., et al. No evidence of cardiac involvement in ankylosing spondylitis as assessed by heart rate variability. Clin. Rheumatol. 20 3 (2001) 185-188